140 related articles for article (PubMed ID: 27042072)
21. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
Alonso P; Gratacòs M; Menchón JM; Saiz-Ruiz J; Segalàs C; Baca-García E; Labad J; Fernández-Piqueras J; Real E; Vaquero C; Pérez M; Dolengevich H; González JR; Bayés M; de Cid R; Vallejo J; Estivill X
Biol Psychiatry; 2008 Mar; 63(6):619-28. PubMed ID: 17884018
[TBL] [Abstract][Full Text] [Related]
22. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P
J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664
[TBL] [Abstract][Full Text] [Related]
23. The role of the brain-derived neurotrophic factor SNP rs2883187 in the phenotypic expression of obsessive-compulsive disorder.
Tükel R; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Direskeneli GS
J Clin Neurosci; 2014 May; 21(5):790-3. PubMed ID: 24291483
[TBL] [Abstract][Full Text] [Related]
24. Effect of genetic polymorphism of brain-derived neurotrophic factor and serotonin transporter on smoking phenotypes: A pilot study of Japanese participants.
Ohmoto M; Takahashi T
Heliyon; 2019 Feb; 5(2):e01234. PubMed ID: 30815604
[TBL] [Abstract][Full Text] [Related]
25. A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder.
Wendland JR; Kruse MR; Cromer KR; Murphy DL
Neuropsychopharmacology; 2007 Dec; 32(12):2543-51. PubMed ID: 17375136
[TBL] [Abstract][Full Text] [Related]
26. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
27. The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.
González-Castro TB; Nicolini H; Lanzagorta N; López-Narváez L; Genis A; Pool García S; Tovilla-Zárate CA
Bipolar Disord; 2015 Feb; 17(1):27-38. PubMed ID: 25041243
[TBL] [Abstract][Full Text] [Related]
28. Interactions of
Low I; Kuo PC; Tsai CL; Liu YH; Lin MW; Chao HT; Chen YS; Hsieh JC; Chen LF
Front Neurosci; 2018; 12():826. PubMed ID: 30524221
[TBL] [Abstract][Full Text] [Related]
29. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
Zhang XY; Chen DC; Tan YL; Luo X; Zuo L; Lv MH; Shah NN; Zunta-Soares GB; Soares JC
J Psychiatr Res; 2015 Jan; 60():49-55. PubMed ID: 25455509
[TBL] [Abstract][Full Text] [Related]
30. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor.
Stein DJ; Van Heerden B; Wessels CJ; Van Kradenburg J; Warwick J; Wasserman HJ
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):1079-99. PubMed ID: 10621951
[TBL] [Abstract][Full Text] [Related]
31. Val66Met polymorphism in the BDNF gene in children with bronchial asthma.
Jesenak M; Babusikova E; Evinova A; Banovcin P; Dobrota D
Pediatr Pulmonol; 2015 Jul; 50(7):631-7. PubMed ID: 24863266
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: a case-control study.
Maina G; Rosso G; Zanardini R; Bogetto F; Gennarelli M; Bocchio-Chiavetto L
J Affect Disord; 2010 Apr; 122(1-2):174-8. PubMed ID: 19664825
[TBL] [Abstract][Full Text] [Related]
33. BDNF Val66Met polymorphism is associated with Stage III-IV endometriosis and poor in vitro fertilization outcome.
Zhang QY; Guan Q; Wang Y; Feng X; Sun W; Kong FY; Wen J; Cui W; Yu Y; Chen ZY
Hum Reprod; 2012 Jun; 27(6):1668-75. PubMed ID: 22447624
[TBL] [Abstract][Full Text] [Related]
34. Exploring the association between BDNF Val66Met polymorphism and suicidal behavior: Meta-analysis and systematic review.
González-Castro TB; Salas-Magaña M; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Hernández-Díaz Y
J Psychiatr Res; 2017 Nov; 94():208-217. PubMed ID: 28756290
[TBL] [Abstract][Full Text] [Related]
35. A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder.
Real E; Gratacòs M; Soria V; Escaramís G; Alonso P; Segalàs C; Bayés M; de Cid R; Menchón JM; Estivill X
Biol Psychiatry; 2009 Oct; 66(7):674-80. PubMed ID: 19589503
[TBL] [Abstract][Full Text] [Related]
36. Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder.
Sharma LP; Reddy YCJ
Indian J Psychiatry; 2019 Jan; 61(Suppl 1):S140-S148. PubMed ID: 30745688
[TBL] [Abstract][Full Text] [Related]
37. Association of the Brain-derived Neurotrophic Factor Gene and Clinical Features of Bipolar Disorder in Korea.
Min HJ; Cho HS; Kim SJ; Seok JH; Lee E; Jon DI
Clin Psychopharmacol Neurosci; 2012 Dec; 10(3):163-7. PubMed ID: 23430274
[TBL] [Abstract][Full Text] [Related]
38. Neurotrophic factors in obsessive-compulsive disorder.
Fontenelle LF; Barbosa IG; Luna JV; Rocha NP; Silva Miranda A; Teixeira AL
Psychiatry Res; 2012 Oct; 199(3):195-200. PubMed ID: 22494702
[TBL] [Abstract][Full Text] [Related]
39. Association analysis of SLC6A4 and HTR2A genes with obsessive-compulsive disorder: Influence of the STin2 polymorphism.
Gomes CKF; Vieira-Fonseca T; Melo-Felippe FB; de Salles Andrade JB; Fontenelle LF; Kohlrausch FB
Compr Psychiatry; 2018 Apr; 82():1-6. PubMed ID: 29331882
[TBL] [Abstract][Full Text] [Related]
40. The BDNF Val66Met polymorphism moderates the relationship between Posttraumatic Stress Disorder and fear extinction learning.
Felmingham KL; Zuj DV; Hsu KCM; Nicholson E; Palmer MA; Stuart K; Vickers JC; Malhi GS; Bryant RA
Psychoneuroendocrinology; 2018 May; 91():142-148. PubMed ID: 29550677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
